TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Adipose Tissue-derived Stem Cell Therapy Market Research Report 2024(Status and Outlook)

Global Adipose Tissue-derived Stem Cell Therapy Market Research Report 2024(Status and Outlook)

  • Category:Life Sciences
  • Published on : 04 December 2024
  • Pages :141
  • Formats:
  • Report Code:SMR-8021215
OfferClick for best price

Best Price: $2600

Adipose Tissuederived Stem Cell Therapy Market Size, Share 2024


Market size in 2024 US$ 578.9 million
Forecast Market size by 2030 US$ 1.01 billion
Growth Rate CAGR of 9.8% Number of Pages 141 Pages

The global Adipose Tissue-derived Stem Cell Therapy market size was valued at US$ 578.9 million in 2024 and is projected to reach US$ 1.01 billion by 2030, at a CAGR of 9.8% during the forecast period 2024-2030.

The United States Adipose Tissue-derived Stem Cell Therapy market size was valued at US$ 167.8 million in 2024 and is projected to reach US$ 287.6 million by 2030, at a CAGR of 9.4% during the forecast period 2024-2030.

Stem cell treatments using adipose tissue sources.

Medical research drives 53% of demand. Clinical applications influence 45% of adoption. Treatment results affect 42% of selection. Patient outcomes show 40% correlation with protocols. Research advances drive 35% of innovation. Treatment costs affect 32% of accessibility.

Report Overview

Adipose tissue stem cells (ASCs), known as multipotent stem cells, are most commonly used in the clinical applications in recent years.

This report provides a deep insight into the global Adipose Tissue-derived Stem Cell Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Adipose Tissue-derived Stem Cell Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Adipose Tissue-derived Stem Cell Therapy market in any manner.

Global Adipose Tissue-derived Stem Cell Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AlloCure

Antria

Celgene Corporation

Cellleris

Corestem

Cytori Therapeutics

Intrexon

Mesoblast

Pluristem Therapeutics

Tissue Genesis

BioRestorative Therapies

Celltex Therapeutics Corporation

iXCells Biotechnologies

Pluristem Therapeutics

Cyagen

Lonza

Market Segmentation (by Type)

Autologous Stem Cells

Allogeneic Stem Cells

Market Segmentation (by Application)

Therapeutic Application

Research Application

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Adipose Tissue-derived Stem Cell Therapy Market

Overview of the regional outlook of the Adipose Tissue-derived Stem Cell Therapy Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter

Report Attributes Report Details
Report Title Global Adipose Tissue-derived Stem Cell Therapy Market Research Report 2024(Status and Outlook)
Market size in 2024 US$ 578.9 million
Forecast Market size by 2030 US$ 1.01 billion
Growth Rate CAGR of 9.8%
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 141 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Adipose Tissue-derived Stem Cell Therapy
1.2 Key Market Segments
1.2.1 Adipose Tissue-derived Stem Cell Therapy Segment by Type
1.2.2 Adipose Tissue-derived Stem Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Adipose Tissue-derived Stem Cell Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Adipose Tissue-derived Stem Cell Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Adipose Tissue-derived Stem Cell Therapy Market Competitive Landscape
3.1 Global Adipose Tissue-derived Stem Cell Therapy Sales by Manufacturers (2019-2024)
3.2 Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Adipose Tissue-derived Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Adipose Tissue-derived Stem Cell Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Adipose Tissue-derived Stem Cell Therapy Sales Sites, Area Served, Product Type
3.6 Adipose Tissue-derived Stem Cell Therapy Market Competitive Situation and Trends
3.6.1 Adipose Tissue-derived Stem Cell Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adipose Tissue-derived Stem Cell Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Adipose Tissue-derived Stem Cell Therapy Industry Chain Analysis
4.1 Adipose Tissue-derived Stem Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Adipose Tissue-derived Stem Cell Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Adipose Tissue-derived Stem Cell Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Type (2019-2024)
6.3 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Adipose Tissue-derived Stem Cell Therapy Price by Type (2019-2024)
7 Adipose Tissue-derived Stem Cell Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adipose Tissue-derived Stem Cell Therapy Market Sales by Application (2019-2024)
7.3 Global Adipose Tissue-derived Stem Cell Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Adipose Tissue-derived Stem Cell Therapy Sales Growth Rate by Application (2019-2024)
8 Adipose Tissue-derived Stem Cell Therapy Market Segmentation by Region
8.1 Global Adipose Tissue-derived Stem Cell Therapy Sales by Region
8.1.1 Global Adipose Tissue-derived Stem Cell Therapy Sales by Region
8.1.2 Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Adipose Tissue-derived Stem Cell Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adipose Tissue-derived Stem Cell Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adipose Tissue-derived Stem Cell Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adipose Tissue-derived Stem Cell Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AlloCure
9.1.1 AlloCure Adipose Tissue-derived Stem Cell Therapy Basic Information
9.1.2 AlloCure Adipose Tissue-derived Stem Cell Therapy Product Overview
9.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.1.4 AlloCure Business Overview
9.1.5 AlloCure Adipose Tissue-derived Stem Cell Therapy SWOT Analysis
9.1.6 AlloCure Recent Developments
9.2 Antria
9.2.1 Antria Adipose Tissue-derived Stem Cell Therapy Basic Information
9.2.2 Antria Adipose Tissue-derived Stem Cell Therapy Product Overview
9.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.2.4 Antria Business Overview
9.2.5 Antria Adipose Tissue-derived Stem Cell Therapy SWOT Analysis
9.2.6 Antria Recent Developments
9.3 Celgene Corporation
9.3.1 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Basic Information
9.3.2 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Overview
9.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.3.4 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy SWOT Analysis
9.3.5 Celgene Corporation Business Overview
9.3.6 Celgene Corporation Recent Developments
9.4 Cellleris
9.4.1 Cellleris Adipose Tissue-derived Stem Cell Therapy Basic Information
9.4.2 Cellleris Adipose Tissue-derived Stem Cell Therapy Product Overview
9.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.4.4 Cellleris Business Overview
9.4.5 Cellleris Recent Developments
9.5 Corestem
9.5.1 Corestem Adipose Tissue-derived Stem Cell Therapy Basic Information
9.5.2 Corestem Adipose Tissue-derived Stem Cell Therapy Product Overview
9.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.5.4 Corestem Business Overview
9.5.5 Corestem Recent Developments
9.6 Cytori Therapeutics
9.6.1 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Basic Information
9.6.2 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Overview
9.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.6.4 Cytori Therapeutics Business Overview
9.6.5 Cytori Therapeutics Recent Developments
9.7 Intrexon
9.7.1 Intrexon Adipose Tissue-derived Stem Cell Therapy Basic Information
9.7.2 Intrexon Adipose Tissue-derived Stem Cell Therapy Product Overview
9.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.7.4 Intrexon Business Overview
9.7.5 Intrexon Recent Developments
9.8 Mesoblast
9.8.1 Mesoblast Adipose Tissue-derived Stem Cell Therapy Basic Information
9.8.2 Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Overview
9.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.8.4 Mesoblast Business Overview
9.8.5 Mesoblast Recent Developments
9.9 Pluristem Therapeutics
9.9.1 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Basic Information
9.9.2 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Overview
9.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.9.4 Pluristem Therapeutics Business Overview
9.9.5 Pluristem Therapeutics Recent Developments
9.10 Tissue Genesis
9.10.1 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Basic Information
9.10.2 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Overview
9.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.10.4 Tissue Genesis Business Overview
9.10.5 Tissue Genesis Recent Developments
9.11 BioRestorative Therapies
9.11.1 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Basic Information
9.11.2 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Overview
9.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.11.4 BioRestorative Therapies Business Overview
9.11.5 BioRestorative Therapies Recent Developments
9.12 Celltex Therapeutics Corporation
9.12.1 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Basic Information
9.12.2 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Overview
9.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.12.4 Celltex Therapeutics Corporation Business Overview
9.12.5 Celltex Therapeutics Corporation Recent Developments
9.13 iXCells Biotechnologies
9.13.1 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Basic Information
9.13.2 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Overview
9.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.13.4 iXCells Biotechnologies Business Overview
9.13.5 iXCells Biotechnologies Recent Developments
9.14 Pluristem Therapeutics
9.14.1 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Basic Information
9.14.2 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Overview
9.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.14.4 Pluristem Therapeutics Business Overview
9.14.5 Pluristem Therapeutics Recent Developments
9.15 Cyagen
9.15.1 Cyagen Adipose Tissue-derived Stem Cell Therapy Basic Information
9.15.2 Cyagen Adipose Tissue-derived Stem Cell Therapy Product Overview
9.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.15.4 Cyagen Business Overview
9.15.5 Cyagen Recent Developments
9.16 Lonza
9.16.1 Lonza Adipose Tissue-derived Stem Cell Therapy Basic Information
9.16.2 Lonza Adipose Tissue-derived Stem Cell Therapy Product Overview
9.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.16.4 Lonza Business Overview
9.16.5 Lonza Recent Developments
10 Adipose Tissue-derived Stem Cell Therapy Market Forecast by Region
10.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast
10.2 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Region
10.2.4 South America Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adipose Tissue-derived Stem Cell Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Adipose Tissue-derived Stem Cell Therapy by Type (2025-2030)
11.1.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Adipose Tissue-derived Stem Cell Therapy by Type (2025-2030)
11.2 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adipose Tissue-derived Stem Cell Therapy Market Size Comparison by Region (M USD)
Table 5. Global Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Adipose Tissue-derived Stem Cell Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Adipose Tissue-derived Stem Cell Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adipose Tissue-derived Stem Cell Therapy as of 2022)
Table 10. Global Market Adipose Tissue-derived Stem Cell Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Adipose Tissue-derived Stem Cell Therapy Sales Sites and Area Served
Table 12. Manufacturers Adipose Tissue-derived Stem Cell Therapy Product Type
Table 13. Global Adipose Tissue-derived Stem Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Adipose Tissue-derived Stem Cell Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Adipose Tissue-derived Stem Cell Therapy Market Challenges
Table 22. Global Adipose Tissue-derived Stem Cell Therapy Sales by Type (Kilotons)
Table 23. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type (M USD)
Table 24. Global Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Adipose Tissue-derived Stem Cell Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Adipose Tissue-derived Stem Cell Therapy Market Size Share by Type (2019-2024)
Table 28. Global Adipose Tissue-derived Stem Cell Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons) by Application
Table 30. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application
Table 31. Global Adipose Tissue-derived Stem Cell Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Adipose Tissue-derived Stem Cell Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2019-2024)
Table 35. Global Adipose Tissue-derived Stem Cell Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Adipose Tissue-derived Stem Cell Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Adipose Tissue-derived Stem Cell Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Adipose Tissue-derived Stem Cell Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Adipose Tissue-derived Stem Cell Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Adipose Tissue-derived Stem Cell Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. AlloCure Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 44. AlloCure Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 45. AlloCure Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AlloCure Business Overview
Table 47. AlloCure Adipose Tissue-derived Stem Cell Therapy SWOT Analysis
Table 48. AlloCure Recent Developments
Table 49. Antria Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 50. Antria Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 51. Antria Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Antria Business Overview
Table 53. Antria Adipose Tissue-derived Stem Cell Therapy SWOT Analysis
Table 54. Antria Recent Developments
Table 55. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 56. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 57. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy SWOT Analysis
Table 59. Celgene Corporation Business Overview
Table 60. Celgene Corporation Recent Developments
Table 61. Cellleris Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 62. Cellleris Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 63. Cellleris Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Cellleris Business Overview
Table 65. Cellleris Recent Developments
Table 66. Corestem Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 67. Corestem Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 68. Corestem Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Corestem Business Overview
Table 70. Corestem Recent Developments
Table 71. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 72. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 73. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Cytori Therapeutics Business Overview
Table 75. Cytori Therapeutics Recent Developments
Table 76. Intrexon Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 77. Intrexon Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 78. Intrexon Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Intrexon Business Overview
Table 80. Intrexon Recent Developments
Table 81. Mesoblast Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 82. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 83. Mesoblast Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Mesoblast Business Overview
Table 85. Mesoblast Recent Developments
Table 86. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 87. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 88. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Pluristem Therapeutics Business Overview
Table 90. Pluristem Therapeutics Recent Developments
Table 91. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 92. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 93. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Tissue Genesis Business Overview
Table 95. Tissue Genesis Recent Developments
Table 96. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 97. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 98. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. BioRestorative Therapies Business Overview
Table 100. BioRestorative Therapies Recent Developments
Table 101. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 102. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 103. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Celltex Therapeutics Corporation Business Overview
Table 105. Celltex Therapeutics Corporation Recent Developments
Table 106. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 107. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 108. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. iXCells Biotechnologies Business Overview
Table 110. iXCells Biotechnologies Recent Developments
Table 111. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 112. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 113. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Pluristem Therapeutics Business Overview
Table 115. Pluristem Therapeutics Recent Developments
Table 116. Cyagen Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 117. Cyagen Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 118. Cyagen Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Cyagen Business Overview
Table 120. Cyagen Recent Developments
Table 121. Lonza Adipose Tissue-derived Stem Cell Therapy Basic Information
Table 122. Lonza Adipose Tissue-derived Stem Cell Therapy Product Overview
Table 123. Lonza Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Lonza Business Overview
Table 125. Lonza Recent Developments
Table 126. Global Adipose Tissue-derived Stem Cell Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Adipose Tissue-derived Stem Cell Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Adipose Tissue-derived Stem Cell Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Adipose Tissue-derived Stem Cell Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Adipose Tissue-derived Stem Cell Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Adipose Tissue-derived Stem Cell Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Adipose Tissue-derived Stem Cell Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Adipose Tissue-derived Stem Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adipose Tissue-derived Stem Cell Therapy Market Size (M USD), 2019-2030
Figure 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Adipose Tissue-derived Stem Cell Therapy Market Size by Country (M USD)
Figure 11. Adipose Tissue-derived Stem Cell Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Adipose Tissue-derived Stem Cell Therapy Revenue Share by Manufacturers in 2023
Figure 13. Adipose Tissue-derived Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Adipose Tissue-derived Stem Cell Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Adipose Tissue-derived Stem Cell Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Type
Figure 18. Sales Market Share of Adipose Tissue-derived Stem Cell Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Adipose Tissue-derived Stem Cell Therapy by Type in 2023
Figure 20. Market Size Share of Adipose Tissue-derived Stem Cell Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Adipose Tissue-derived Stem Cell Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Application
Figure 24. Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Application in 2023
Figure 26. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2019-2024)
Figure 27. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Application in 2023
Figure 28. Global Adipose Tissue-derived Stem Cell Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Adipose Tissue-derived Stem Cell Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Country in 2023
Figure 37. Germany Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Region in 2023
Figure 44. China Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Adipose Tissue-derived Stem Cell Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Adipose Tissue-derived Stem Cell Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Adipose Tissue-derived Stem Cell Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Adipose Tissue-derived Stem Cell Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Adipose Tissue-derived Stem Cell Therapy Market Share Forecast by Application (2025-2030)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount